Li Yuanyuan, Wang Qiang, Zhong Wenjun, Pan Xinfeng, Zhang Minhong, Chi Liqiao
Department of Dermatology, Qingpu Branch of Zhongshan Hospital, Fudan University Shanghai, China.
Am J Transl Res. 2024 Dec 15;16(12):7364-7373. doi: 10.62347/FRPZ7345. eCollection 2024.
To analyze the clinical application value of CO laser combined with 5-aminolevulinic acid photodynamic therapy for periungual and plantar warts.
Data from patients with periungual and plantar warts treated at Qingpu branch of Zhongshan Hospital, Fudan University between August 2022 and January 2024 were retrospectively analyzed. After screening based on inclusion and exclusion criteria, 96 patients were included and categorized into two groups according to their treatment regimens: a combination group (n=50, receiving CO laser therapy and 5-aminolevulinic acid photodynamic therapy) and a control group (n=46, undergoing CO laser treatment alone). The two groups were compared in terms of wart scores before and after treatment, clinical efficacy, recurrence rates during follow-up, and incidence of adverse reactions.
During the 4th, 6th, and 8th weeks of treatment, the wart scores of patients in the combination group were significantly lower than those of the control group (<0.05), and at these intervals, the overall treatment efficacy in the combination group was significantly higher than that of the control group (<0.05). At 3-month follow-up, the recurrence rate in the combination group (2.00%) was lower than that in the control group (10.87%) (<0.05). At the 2nd, 4th, 6th, and 8th weeks of treatment, the Visual Analog Scale scores in the combination group were significantly reduced compared to the control group (<0.05). No significant difference was found in the incidence of adverse reactions between the two groups during follow-up (>0.05).
The application of CO laser therapy combined with 5-aminolevulinic acid photodynamic therapy is effective for patients suffering from periungual and plantar warts, and this combination enhances clinical outcome, mitigates pain, and reduces short-term recurrence.
分析CO2激光联合5-氨基酮戊酸光动力疗法治疗甲周疣和跖疣的临床应用价值。
回顾性分析2022年8月至2024年1月在复旦大学附属中山医院青浦分院接受治疗的甲周疣和跖疣患者的数据。根据纳入和排除标准进行筛选后,纳入96例患者,并根据治疗方案将其分为两组:联合组(n=50,接受CO2激光治疗和5-氨基酮戊酸光动力疗法)和对照组(n=46,仅接受CO2激光治疗)。比较两组治疗前后的疣体评分、临床疗效、随访期间的复发率以及不良反应发生率。
在治疗的第4、6和8周,联合组患者的疣体评分显著低于对照组(<0.05),且在这些时间点,联合组的总体治疗效果显著高于对照组(<0.05)。在3个月的随访中,联合组的复发率(2.00%)低于对照组(10.87%)(<0.05)。在治疗的第2、4、6和8周,联合组的视觉模拟评分与对照组相比显著降低(<0.05)。随访期间两组不良反应发生率无显著差异(>0.05)。
CO2激光治疗联合5-氨基酮戊酸光动力疗法对甲周疣和跖疣患者有效,这种联合疗法可提高临床疗效、减轻疼痛并降低短期复发率。